Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023

SELL
$43.42 - $57.37 $105,293 - $139,122
-2,425 Reduced 22.15%
8,525 $411,000
Q4 2022

Feb 03, 2023

BUY
$38.8 - $55.46 $19,400 - $27,730
500 Added 4.78%
10,950 $546,000
Q3 2022

Oct 26, 2022

SELL
$38.15 - $57.1 $26,705 - $39,970
-700 Reduced 6.28%
10,450 $426,000
Q2 2022

Jul 22, 2022

BUY
$33.54 - $55.0 $373,971 - $613,250
11,150 New
11,150 $613,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Capital Investment Advisory Services, LLC Portfolio

Follow Capital Investment Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.